AA
Anita Aggarwal
About Anita Aggarwal
Data last updated:
Anita Aggarwal is a Whole-Time Director at Sanjeevan Medical Research Centre Private Limited (since 2002), Director at Minerva Medical Treatment Private Limited (since 2019) and Director at Sanjeevan Drugs Private Limited (since 2000). The companies operate in Healthcare and Internet. The 3 current companies with reported revenue have a combined latest revenue of ₹26.71 Cr; the largest is Sanjeevan Medical Research Centre Private Limited at ₹16.54 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sanjeevan Medical Research Centre Private Limited U74899DL1982PTC013990 | Whole-Time Director | 02 Sep 2002 | 1982 | ₹16.54 Cr (FY 2025) | Active |
 Minerva Medical Treatment Private Limited U74900DL2011PTC214315 | Director | 28 Apr 2019 | 2011 | ₹5.20 Cr (FY 2025) | Active |
| Sanjeevan Drugs Private Limited U33119DL2000PTC107325 | Director | 17 Aug 2000 | 2000 | ₹4.98 Cr (FY 2025) | Active |
Board colleagues of Anita Aggarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prem Aggarwal | 00228410 | Sanjeevan Medical Research Centre Private Limited , Minerva Medical Treatment Private Limited | Managing Director |
| Meghna Aggarwal Singhania | 03172078 | Minerva Medical Treatment Private Limited , Sanjeevan Drugs Private Limited | Director |
| Vidush Pat Singhania | 07309371 | Minerva Medical Treatment Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anita Aggarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anita Aggarwal
Anita Aggarwal currently holds 3 directorships: Sanjeevan Medical Research Centre Private Limited (Whole-Time Director, since 02 Sep 2002, revenue ₹16.54 Cr (FY 2025)); Minerva Medical Treatment Private Limited (Director, since 28 Apr 2019, revenue ₹5.20 Cr (FY 2025)); Sanjeevan Drugs Private Limited (Director, since 17 Aug 2000, revenue ₹4.98 Cr (FY 2025)).
Anita Aggarwal was first appointed on 17 Aug 2000 as Director at Sanjeevan Drugs Private Limited. The most recent appointment on record is 28 Apr 2019 at Minerva Medical Treatment Private Limited.
The 3 current companies of Anita Aggarwal that report revenue have a combined latest revenue of ₹26.71 Cr: Sanjeevan Medical Research Centre Private Limited ₹16.54 Cr (FY 2025); Minerva Medical Treatment Private Limited ₹5.20 Cr (FY 2025); Sanjeevan Drugs Private Limited ₹4.98 Cr (FY 2025).
The current boards of Anita Aggarwal's companies include Prem Aggarwal (Sanjeevan Medical Research Centre Private Limited), Meghna Aggarwal Singhania (Minerva Medical Treatment Private Limited), Vidush Pat Singhania (Minerva Medical Treatment Private Limited).